Inmed to participate in upcoming investor conferences in april and may 2022

Vancouver, british columbia, april 19, 2022 (globe newswire) -- inmed pharmaceuticals inc. (“inmed” or the “company”) (nasdaq: inm), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, announces that the company's executive team will be participating in several investor events throughout april and may 2022.

INM Ratings Summary

INM Quant Ranking